Alpha Cognition Appoints Caren Deardorf to Board

PUBT · 1d ago
Alpha Cognition Appoints Caren Deardorf to Board
  • Alpha Cognition appointed Caren Deardorf to its board on November 5, 2026, effective November 11, 2026.
  • Deardorf has served as chief business and strategy officer at Neutrolis since August 2025.
  • She previously served as chief commercial and strategy officer at Editas Medicine from 2023 to 2025.
  • Deardorf also joins the audit committee and the governance and nomination committee.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-118958), on November 12, 2026, and is solely responsible for the information contained therein.